He Yuanpei, Wang Xinge, Xu Boya, Chen Shichao, Li Hongcai, Chang Bei, Hu Chao, Lan Xiaorong, Li Shiting, Li Guangwen
The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Luzhou, China.
Department of Stomatology, Norman Bethune International Peace Hospital, Shijiazhuang, China.
Front Cell Dev Biol. 2025 Aug 26;13:1643141. doi: 10.3389/fcell.2025.1643141. eCollection 2025.
Mitochondrial transfer is defined the process through which specific cell types release their mitochondria and subsequently transfer them to unrelated cell types in response to various physiological or pathological stimuli. This process enhances cellular function and alters disease states. Recent research has begun to explore the potential of intercellular mitochondrial transfer as a therapeutic strategy for human diseases. Mitochondrial dysfunction represents a significant pathological alteration in osteoarthritis, and studies indicate that mitochondrial transfer may serve as an effective modulatory treatment approach for osteoarthritis. Mitochondrial transfer, as an innovative subcellular therapeutic technique, presents the advantages of diverse acquisition methods and multiple transmission pathways. This paper aims to summarize the current understanding of the mechanisms of mitochondrial transfer in relation to osteoarthritis, emphasizing the existing research on mitochondrial transfer in osteoarthritis and its potential as a disease-modifying therapy.
线粒体转移被定义为特定细胞类型释放其线粒体,随后在各种生理或病理刺激下将它们转移到不相关细胞类型的过程。这一过程增强细胞功能并改变疾病状态。最近的研究已开始探索细胞间线粒体转移作为人类疾病治疗策略的潜力。线粒体功能障碍是骨关节炎的一种重要病理改变,研究表明线粒体转移可能作为骨关节炎的一种有效调节性治疗方法。线粒体转移作为一种创新的亚细胞治疗技术,具有多种获取方法和多条传递途径的优势。本文旨在总结目前对与骨关节炎相关的线粒体转移机制的理解,强调骨关节炎中线粒体转移的现有研究及其作为疾病修饰疗法的潜力。